CHF 4227
Alternative Names: CHF 4227.01Latest Information Update: 04 Nov 2017
At a glance
- Originator Chiesi Farmaceutici
- Class Benzopyrans; Osteoporosis therapies; Piperidines
- Mechanism of Action Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer; Postmenopausal osteoporosis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Postmenopausal-osteoporosis in Italy
- 30 May 2006 This compound is still in active development for Postmenopausal osteoporosis
- 30 May 2006 No development reported - Preclinical for Breast cancer in Italy (unspecified route)